| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3282224 | Clinical Gastroenterology and Hepatology | 2015 | 7 Pages |
Abstract
In patients with ASUC, an accelerated infliximab induction strategy reduces the need for early colectomy. An intensified infliximab dosing strategy in response to clinical or laboratory signs of breakthrough inflammation merits consideration in prospective studies.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
David J. Gibson, Zaid S. Heetun, Ciaran E. Redmond, Kavin S. Nanda, Denise Keegan, Kathryn Byrne, Hugh E. Mulcahy, Garret Cullen, Glen A. Doherty,